Ankylosing spondylitis is associated with an increased risk of vertebral and nonvertebral clinical fractures: A population-based cohort study

Journal of Bone and Mineral Research

Volumn 29, Issue 8, 2014, Pages 1770-1776

  Muñoz Ortego, Juan ^a   Vestergaard, Peter ^b   Rubio, Josep Blanch ^c   Wordsworth, Paul ^d   Judge, Andrew ^d,e   Javaid, M Kassim ^d   Arden, Nigel K ^d   Cooper, Cyrus ^d,e   Díez Pérez, Adolfo ^f   Prieto Alhambra, Daniel ^d,e,f,g  

^a HOSPITAL UNIVERSITARI SAGRAT COR   (Spain)

^b AALBORG UNIVERSITY HOSPITAL   (Denmark)

^c Rheumatology Department   (Spain)

^d NUFFIELD ORTHOPAEDIC CENTRE   (United Kingdom)

^e UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^f INSTITUTO DE SALUD CARLOS III   (Spain)

^g UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Bone; Electronic Health Records; Epidemiology; Fracture; Spondylitis; Spondyloarthropathy

Indexed keywords

CORTICOSTEROID; NONSTEROID ANTIINFLAMMATORY AGENT; STEROID;

ADOLESCENT; ADULT; AGED; ALCOHOL CONSUMPTION; ANKYLOSING SPONDYLITIS; ARTICLE; BODY MASS; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DEATH; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; FRACTURE; GENERAL PRACTICE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; NONVERTEBRAL FRACTURE; PATIENT RISK; POPULATION; PREVALENCE; PRIMARY MEDICAL CARE; PUBLIC HEALTH; RISK ASSESSMENT; RISK FACTOR; SMOKING; SPINE FRACTURE; COMPLICATION; FRACTURES, BONE; MIDDLE AGED; SPINAL FRACTURES;

COHORT STUDIES; FEMALE; FRACTURES, BONE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; SPINAL FRACTURES; SPONDYLITIS, ANKYLOSING;

EID: 84901672262     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.2217     Document Type: Article

References (29)

1. Sieper J, Appel H, Braun J, Rudwaleit M., Critical appraisal of assessment of structural damage in ankylosing spondylitis: implications for treatment outcomes. Arthritis Rheum. 2008; 58 (3): 649-56.
2. Arends S, Spoorenberg A, Bruyn GA, et al. The relation between bone mineral density, bone turnover markers, and vitamin D status in ankylosing spondylitis patients with active disease: a cross-sectional analysis. Osteoporos Int. 2011; 22 (5): 1431-9.
3. Franck H, Meurer T, Hofbauer LC., Evaluation of bone mineral density, hormones, biochemical markers of bone metabolism, and osteoprotegerin serum levels in patients with ankylosing spondylitis. J Rheumatol. 2004; 31 (11): 2236-41.
4. Will R, Palmer R, Bhalla AK, Ring F, Calin A., Osteoporosis in early ankylosing spondylitis: a primary pathological event ? Lancet. 1989; 2 (8678-8679): 1483-5.
5. van der Weijden MA, Claushuis TA, Nazari T, Lems WF, Dijkmans BA, van der Horst-Bruinsma IE., High prevalence of low bone mineral density in patients within 10 years of onset of ankylosing spondylitis: a systematic review. Clin Rheumatol. 2012; 31 (11): 1529-35.
6. van der Weijden MA, van der Horst-Bruinsma IE, van Denderen JC, Dijkmans BA, Heymans MW, Lems WF., High frequency of vertebral fractures in early spondyloarthropathies. Osteoporos Int. 2012; 23 (6): 1683-90.
7. Westerveld LA, Verlaan JJ, Oner FC., Spinal fractures in patients with ankylosing spinal disorders: a systematic review of the literature on treatment, neurological status and complications. Eur Spine J. 2009; 18 (2): 145-56.
8. Bultink IE, Vis M, van der Horst-Bruinsma IE, Lems WF., Inflammatory rheumatic disorders and bone. Curr Rheumatol Rep. 2012; 14 (3): 224-30.
9. Graham B, Van Peteghem PK., Fractures of the spine in ankylosing spondylitis. Diagnosis, treatment, and complications. Spine (Phila Pa 1976). 1989; 14 (8): 803-7.
10. Fox MW, Onofrio BM, Kilgore JE., Neurological complications of ankylosing spondylitis. J Neurosurg. 1993; 78 (6): 871-8.
11. Kroon F, Landewe R, Dougados M, van der Heijde D., Continuous NSAID use reverts the effects of inflammation on radiographic progression in patients with ankylosing spondylitis. Ann Rheum Dis. 2012; 71 (10): 1623-9.
12. Wanders A, Heijde D, Landewe R, et al. Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial. Arthritis Rheum. 2005; 52 (6): 1756-65.
13. van der Heijde D, Sieper J, Maksymowych WP, et al. 2011 Update of the international ASAS recommendations for the use of anti-TNF agents in patients with axial spondyloarthritis. Ann Rheum Dis. 2010; 70 (6): 905-8.
14. Allali F, Breban M, Porcher R, Maillefert JF, Dougados M, Roux C., Increase in bone mineral density of patients with spondyloarthropathy treated with anti-tumour necrosis factor alpha. Ann Rheum Dis. 2003; 62 (4): 347-9.
15. Donnelly S, Doyle DV, Denton A, Rolfe I, McCloskey EV, Spector TD., Bone mineral density and vertebral compression fracture rates in ankylosing spondylitis. Ann Rheum Dis. 1994; 53 (2): 117-21.
16. Cooper C, Carbone L, Michet CJ, Atkinson EJ, O'Fallon WM, Melton LJ 3rd., Fracture risk in patients with ankylosing spondylitis: a population based study. J Rheumatol. 1994; 21 (10): 1877-82.
17. Ralston SH, Urquhart GD, Brzeski M, Sturrock RD., Prevalence of vertebral compression fractures due to osteoporosis in ankylosing spondylitis. BMJ. 1990; 300 (6724): 563-5.
18. Vosse D, Landewe R, van der Heijde D, van der Linden S, van Staa TP, Geusens P., Ankylosing spondylitis and the risk of fracture: results from a large primary care-based nested case-control study. Ann Rheum Dis. 2009; 68 (12): 1839-42.
19. Montala N, Juanola X, Collantes E, et al. Prevalence of vertebral fractures by semiautomated morphometry in patients with ankylosing spondylitis. J Rheumatol. 2011; 38 (5): 893-7.
20. Garcia-Gil Mdel M, Hermosilla E, Prieto-Alhambra D, et al. Construction and validation of a scoring system for the selection of high-quality data in a Spanish population primary care database (SIDIAP). Inform Prim Care. 2012; 19 (3): 135-45.
21. Pages-Castella A, Carbonell-Abella C, Aviles FF, et al. Burden of osteoporotic fractures in primary health care in Catalonia (Spain): a population-based study. BMC Musculoskelet Disord. 2012; 13: 79.
22. Royston P, Carlin JB, White IR., Multiple imputation of missing values: new features for mim. Stata J. 2009; 9 (2): 252-64.
23. Sterne JA, White IR, Carlin JB, et al. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ. 2009; 338: b2393.
24. Blackwell KA, Raisz LG, Pilbeam CC., Prostaglandins in bone: bad cop, good cop ? Trends Endocrinol Metab. 2010; 21 (5): 294-301.
25. Ghozlani I, Ghazi M, Nouijai A, et al. Prevalence and risk factors of osteoporosis and vertebral fractures in patients with ankylosing spondylitis. Bone. 2009; 44 (5): 772-6.
26. Geusens P, Vosse D, van der Heijde D, et al. High prevalence of thoracic vertebral deformities and discal wedging in ankylosing spondylitis patients with hyperkyphosis. J Rheumatol. 2001; 28 (8): 1856-61.
27. Gillespie LD, Robertson MC, Gillespie WJ, et al. Interventions for preventing falls in older people living in the community. Cochrane Database Syst Rev. 2012; 9: CD007146.
28. Costantino F, Talpin A, Said-Nahal R, et al. Prevalence of spondyloarthritis in reference to HLA-B27 in the French population: results of the GAZEL cohort. Ann Rheum Dis. Forthcoming. Epub. 2013 Dec 18. DOI: 10.1136/annrheumdis-2013-204436.
29. Braun J, Bollow M, Remlinger G, et al. Prevalence of spondyloarthropathies in HLA-B27 positive and negative blood donors. Arthritis Rheum. 1998; 41 (1): 58-67.